Literature DB >> 1646683

Trebling of the incidence of testicular cancer in victoria, Australia (1950-1985).

J M Stone1, D G Cruickshank, T F Sandeman, J P Matthews.   

Abstract

Changes in the incidence of testicular cancer in Victoria, Australia were studied from 1950 to 1985. Cases from the period 1950 to 1978 were derived from many sources (1116 cases). Emphasis was placed on diagnostic reliability; 97% of cases were confirmed histologically, and of these, 86% were reviewed at the Peter MacCallum Cancer Institute. For the years 1982 to 1985, Victorian Cancer Registry data were used. The incidence rose by a factor of 2.9 from 1.44 (95% confidence interval [CI], 1.15 to 1.73) per 100,000 in 1950 to 1954 to 4.16 (95% CI, 3.73 to 4.59) per 100,000 in 1982 to 1985. Between 1950 to 1954 and 1965 to 1969, there was a sharp rise, followed by a plateau or dip, then a further rise. Among seminomas, the rates rose in most adult age groups, whereas among nonseminomas, the rise was concentrated in younger age groups. There was a significant trend to earlier age of occurrence among nonseminomas (P = 0.0004) but not among seminomas (P = 0.89). Cohort analysis revealed a trend toward increasing rates for both seminomas and nonseminomas, and confirmed the trend toward earlier age of onset for nonseminomas. Disproportionate increases were observed for the 1915 to 1924 cohort of seminomas and the 1930 to 1939 cohort of nonseminomas. Analysis of available data from other Australian states indicated comparable rising incidence in New South Wales, Tasmania, and Western Australia.

Entities:  

Mesh:

Year:  1991        PMID: 1646683     DOI: 10.1002/1097-0142(19910701)68:1<211::aid-cncr2820680139>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.

Authors:  Armen A Ghazarian; Scott P Kelly; Sean F Altekruse; Philip S Rosenberg; Katherine A McGlynn
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

2.  Retroperitoneal lymph node dissection for metastatic germ cell tumours.

Authors:  N Haldipur; S Devaraj; A Shehata; A K Lewis; M O Smith; M Hatton; A Nassef; J D Beard
Journal:  Ann R Coll Surg Engl       Date:  2011-05       Impact factor: 1.891

3.  Testicular and para-testicular tumors in south western Nigeria.

Authors:  A A Salako; U U Onakpoya; S A Osasan; G O Omoniyi-Esan
Journal:  Afr Health Sci       Date:  2010-03       Impact factor: 0.927

Review 4.  Diagnosis and treatment of patients with testicular germ cell cancer.

Authors:  J T Hartmann; L Kanz; C Bokemeyer
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

Review 5.  Male reproductive health and environmental xenoestrogens.

Authors:  J Toppari; J C Larsen; P Christiansen; A Giwercman; P Grandjean; L J Guillette; B Jégou; T K Jensen; P Jouannet; N Keiding; H Leffers; J A McLachlan; O Meyer; J Müller; E Rajpert-De Meyts; T Scheike; R Sharpe; J Sumpter; N E Skakkebaek
Journal:  Environ Health Perspect       Date:  1996-08       Impact factor: 9.031

6.  Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996.

Authors:  H K Weir; L D Marrett; V Moravan
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

7.  The epidemiology of non-seminomatous germ cell tumours in the west of Scotland 1975-89.

Authors:  M Harding; D Hole; C Gillis
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

Review 8.  Endocrine disrupting compounds exposure and testis development in mammals.

Authors:  Biola F Egbowona; Olajide A Mustapha
Journal:  EXCLI J       Date:  2011-10-10       Impact factor: 4.068

9.  Time trends in accuracy of classification of testicular tumours, with clinical and epidemiological implications.

Authors:  J M Stone; T F Sandeman; P Ironside; D G Cruickshank; J P Matthews
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.